Expanding Psychedelic Medicine - Rick Doblin, Ph.D.

MAPS functions as a non profit pharmaceutical developer working to establish MDMA-assisted psychotherapy as a legally prescribed medical treatment. Founded over three decades ago, the organization seeks to mainstream psychedelic medicine to address widespread mental health challenges, specifically focusing on PTSD treatment. Expansion efforts now aim to move beyond PTSD to explore additional therapeutic indications for MDMA. Success in these clinical trials depends on widespread public and financial support, which allows the necessary legislative and regulatory milestones to become achievable priorities in the current medical landscape.